a |
HS–(CH2)n–COOH, i.e., MHDA |
EDC/NHS, coupling with lysine residues |
165 |
gold slides are incubated overnight
250 μM of MHDA in EtOH and activated by incubation in 2 mM EDC/5
mM NHS solution in MES buffer; after rinsing in PBS, 50 μg/mL of IgG in PBS is added for incubation
(30 min, room temperature) |
• low cost |
• water and air sensitive |
|
|
|
• multiple steps required |
|
|
|
• random orientation |
|
|
|
|
|
|
|
b |
HS–(CH2)n–CHO |
coupling with lysine residues |
27 |
the −NH2 gold chip is immersed
in a 5% glutaraldehyde solution in PBS (2 h at room temperature);
after PBS rinsing and drying, the chip is incubated with a 100 μg/mL
solution of IgG in PBS for 1 h at room temperature |
•
low cost |
• multiple steps required |
|
|
• good stability |
• random orientation |
|
|
|
|
|
|
|
c |
DTSSP |
coupling with cysteine or lysine residues |
3000 |
gold chip is incubated in a 1.5 mM solution of DTSSP in PBS for 1
h at room temperature; after rinsing, slides are incubated with 40 μg/mL of IgG in PBS solution for 30 min
at room temperature |
• short time |
• water and air sensitive |
|
|
|
• high cost |
|
|
|
•
random orientation |
|
|
|
|
|
|
|
d |
CS2/NH2–(CH2)n–NH2
|
coupling with lysine residues |
0.08 |
gold slides are immersed in
a mixed solution (1:1, v/v) of 0.1
M CS2 in water and 20 μg/mL of IgG in PBS solution for 2 h at 4 °C |
•
low cost |
• random orientation |
|
|
•
short time |
|
|
|
• good stability |
|
|
|
|
|
|
|
|
e |
HS–(CH2)n–NH2, i.e., cysteamine |
coupling with acid residues activated by EDC/NHS |
40 |
1 mg/mL solution of IgG is activated by incubation in 2 mM EDC/5 mM NHS
solution in MES buffer (15 min at r.t.); after quenching using 2-mercaptoethanol
(1.2 μL) and purification by desalting column, the solution
in PBS is used for incubation (30 min, room temperature) of the functionalized
gold chip |
• low cost |
• water
and air sensitive |
|
|
• right orientation |
• multiple steps required |
|
|
|
•
Ab clustering |